Faculty, Staff and Student Publications

Publication Date

11-10-2023

Journal

Med

Abstract

Frontline treatment and resultant cure rates in patients with advanced ovarian cancer have changed little over the past several decades. Here, we outline a multidisciplinary approach aimed at gaining novel therapeutic insights by focusing on the poorly understood minimal residual disease phase of ovarian cancer that leads to eventual incurable recurrences.

Keywords

Humans, Female, Neoplasm, Residual, Ovarian Neoplasms, Carcinoma, Ovarian Epithelial

DOI

10.1016/j.medj.2023.08.004

PMID

37951209

PMCID

PMC11275633

PubMedCentral® Posted Date

July 2024

PubMedCentral® Full Text Version

Author MSS

Published Open-Access

yes

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.